Swiss CDMO may be struggling in some areas, but it is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth. The CDMO today said it will expand its bioconjugation facility in Visp, Switzerland even as the facility was approved for the third time for production… Read More: Lonza expanding ADC production as pharma business thrives »
Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More: Horizon Pharma plc Announces FDA Approval to Expand the Age… »
With the growth of industries like pharma and refineries, the demand for high-end intermediates has also increased drastically over a period. In the pharma industry, starting from the raw material applications to the final stages the drug intermediates play a vital role. These are also used in various kinds of medical formulations or other allied… Read More: Working View Of Pharma Intermediates And How To Choose The… »